Search for Abstracts Find by Title, Author or Description Year Abstracts - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first All Abstracts NANETS 2021 Virtual Symposium Published in 2021 Download [B10] Haas - Novel Fusion Gene UBTF-MAML3 Drives Tumorigenesis in Neuroendocrine Tumor Cells Published in 2021 Listed under Poster Download [B11] Guenter - Variability of Somatostatin Receptor Type 2 Immunohistochemical Staining Patterns Among Published in 2021 Listed under Poster Download [B12] Keutgen - Sunitinib-loaded Chondroitin Sulfate Hydrogels as a Novel Drug-delivery Mechanism for the Treatment of Pancreatic Published in 2021 Listed under Poster Download [B13] Jacenik - The MAP Kinase-activated Protein Kinase 2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Involving Action Mediated by Published in 2021 Listed under Poster Download [B14] Beyer - Establishment of Two Patient-derived Neuroendocrine Carcinoma Spheroid and Xenograft Models for Drug Testing Published in 2021 Download [B15] Tran - Comparison of Drug Sensitivity Profiles of Various NEN Spheroids Published in 2021 Listed under Poster Download [B16] Chauhan - Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [B17] Liu - Pre-clinical Evaluation of Alpha-particle Radiotherapy Targeting CXCR4 in Small Cell Lung Cancer Published in 2021 Listed under Poster Download [B1] Ivanov - Sex-specific Transcriptional Differences and Loss of Gene Imprinting in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B2] Tran - RNA-sequencing Identifies Unique Molecular Features of Duodenal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B3] Guo - Cd36 Mediated Metabolic Reprogramming in Cancer Stem Cells Contributes to Drug Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B4] Keutgen - Loss of MEN1 Function Inhibits DNA Repair Capability of Pancreatic Neuroendocrine Tumors after Radiation Published in 2021 Listed under Poster Download [B5] Shaikamjad - RABL6A-Myc Signaling Promotes Pancreatic Neuroendocrine Tumor Cell Proliferation and Survival Published in 2021 Listed under Poster Download [B6] Ear - Inhibition of Serotonin Biosynthesis Suppresses Tumor Published in 2021 Listed under Poster Download [B7] Armstrong - Succinate Accumulation Is Not Sufficient for Tumorigenesis in Mouse Chromaffin Cells But Dual Loss of SDHB and NF1 Yields SDHx-like Pheochromocytomas Published in 2021 Listed under Poster Download [B8] Tow - Development of a Real-time Luminescent Sensor for Detecting Serotonin Levels in Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B9] Whitt - Natural Compound Verrucarin A Potentiates the Anticancer Effect of Etoposide in NET Cell Lines Published in 2021 Listed under Poster Download [C10] McGarrah - Genomic Profiling of Responders and Non-responders to Checkpoint Inhibition in Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C11] Desai - Lurbinectedin in Extrapulmonary Metastatic Neuroendocrine Carcinomas Published in 2021 Listed under Poster Download [C12] Khuong Le - Urinary Neuroendocrine Neoplasms (NENs) Treated in the "Modern Era": A Multicenter Retrospective Review Published in 2021 Listed under Poster Download [C13] Bai - Health-related Quality-of-life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep) Published in 2021 Listed under Poster Download [C14] Mohamed - Exploring Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C15] Al-Toubah - Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C16] Al-Toubah - Efficacy of Ipilimumab and Nivolumab in Patients with Highgrade Neuroendocrine Neoplasms Published in 2021 Listed under Poster Download [C17] Hauser - Treatment Response and Clinical Outcomes of Neuroendocrine Neoplasms (NENs) Treated with Immune Checkpoint Inhibitors (ICIs): a Single Institution Experience Published in 2021 Listed under Poster Download [C18] Shen - A Phase 2 Study of Surufatinib in Combination with Toripalimab in Patients with Advanced Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C19] Chan - Phase 2 Trial of Pembrolizumab-based Therapy in Previously Treated Extrapulmonary Poorly-differentiated Neuroendocrine Carcinomas: Results of Part B Published in 2021 Listed under Poster Download [C1] Gile - Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy in Patients with High-grade Extrapulmonary Published in 2021 Listed under Poster Download [C20] Raj - Randomized Blinded Study Comparing Injection Site Pain From Octreotide Long-acting-release (LAR) Versus Lanreotide During the Treatment of Well-differentiated Published in 2021 Listed under Poster Download [C21] Das - Validation of a Clinical Score (CS) for Patients With WellDifferentiated Neuroendocrine Tumors (WD NETs) Under Consideration for Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C22] Attiyeh - Defining MRI Superiority Over CT for Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C23] Wong - Long-term Outcomes Following 90YRadioembolization of Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C24] Badawy - Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS) Published in 2021 Listed under Poster Download [C25] Weekley - Comparing Periprocedural Hemodynamic Instability in Y-90 Radioembolization and Bland Embolization for Neuroendocrine Tumor Liver Metastases Published in 2021 Listed under Poster Download [C26] Duan - Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Published in 2021 Listed under Poster Download [C27] Zhou - Subgroup Analysis by Ki-67 and Primary Tumor Origins of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Extrapancreatic Neuroendocrine Tumors (SANET-ep) Published in 2021 Listed under Poster Download [C28] Yu - Subgroup Analysis by Ki-67 and Baseline CgA of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Pancreatic Published in 2021 Listed under Poster Download [C29] Clement - Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Advanced Pancreatic Neuroendocrine Tumours (panNETs): Data From the NETTER-R International, Published in 2021 Listed under Poster Download [C2] Mohamed - The Role of Microbiome in Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs) Published in 2021 Listed under Poster Download [C30] Halfdanarson - Compose: Pivotal Phase III Trial of 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade 2 and Grade 3 Gastroenteropancreatic Published in 2021 Listed under Poster Download [C31] Grønbæk - Safety and Effectiveness of 177Lu-Satoreotide Tetraxetan in Patients with Progressive Neuroendocrine Tumors (NETs): Interim Analysis of a Phase I/II Study Published in 2021 Listed under Poster Download [C32] Kunz - The Phase 3 NETTER-1 Study of 177Lu-DOTATATE in Patients with Midgut Neuroendocrine Tumors: Updated Published in 2021 Listed under Poster Download [C33] Norman - Utility of Midpoint Imaging in Patients Receiving Peptide Receptor Radionuclide Therapy (PRRT) for Advance Progressive Gastroenteropancreatic-Neuroendocrine Published in 2021 Listed under Poster Download [C34] Pryma - Secondary Hematological Malignancies Following Highspecific Activity Iodine-131 Metaiodobenzylguanidine Treatment of Advanced Pheochromocytoma and Published in 2021 Listed under Poster Download [C35] Manohar - 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: a Single Center Experience Published in 2021 Listed under Poster Download [C36] Soulen - Cap-Tem-Y90 for Grade 2 Liver-dominant Net Metastases Published in 2021 Listed under Poster Download [C37] Coffman - Treatment Response and Clinical Outcomes of Well-differentiated (WD) High-grade (HG) Neuroendocrine Tumors (NETs) to 177Lu-DOTATATE Published in 2021 Listed under Poster Download [C38] Lawhn-Heath - Clinical Utility of Qualitative Post-treatment SPECT After Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C39] Bodei - Blood-based Genomic Assessment of Clinical Efficacy and Toxicity of 177Lu-DOTATATE of Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C3] Li - Patient-reported Clinical and Productivity Outcomes From the Longitudinal Telotristat Ethyl Treatment Registry Published in 2021 Listed under Poster Download [C40] Gococo-Benore - Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients Published in 2021 Listed under Poster Download [C41] Gupta - Concurrent Everolimus with Hepatic Transarterial Bland Embolotherapy [Evero-Embo] in Patients with Bulky and/or Progressive Metastatic Well Differentiated Neuroendocrine Published in 2021 Listed under Poster Download [C42] Zan - A Case of G3-WD Gastric Carcinoid Tumor in a MEN1 Patient with Discrepant Treatment Response to PRRT in Published in 2021 Listed under Poster Download [C43] Malhotra - MRI Has Improved Detection of Small Neuroendocrine Liver Metastasis Compared with Ga-68 DOTATATE Published in 2021 Listed under Poster Download [C44] Gudmundsdottir - Multifocality Is Not Associated with Worse Survival in Sporadic Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C45] Tran - Management of Duodenal Neuroendocrine Tumors: Surgical Versus Endoscopic Mucosal Resection Published in 2021 Listed under Poster Download [C46] Gudmundsdottir - Alternative Lengthening of Telomeres Is Associated with Aggressive Pathologic Features and Increased Recurrence Risk in Large Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C47] Shi - Pathologic Features of Small Pancreatic Neuroendocrine Tumors with Liver Metastasis Published in 2021 Listed under Poster Download [C48] Shi - Venous Invasion in Resected Pancreatic Neuroendocrine Tumors Is Independently Associated with Disease Free Published in 2021 Listed under Poster Download [C49] Watanabe - Importance of Grade in the Surgical Management of Rectal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C4] Littlejohn - An Open-Label, Phase II Investigation of Trifluridine/Tipiracil in Patients With High-Grade, Extrapulmonary Published in 2021 Download [C50] Slattery - Detection Method and Overall Survival in Surgically Resected Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C51] Naaseh - A Single-Center Experience in Observation of Small Pancreatic Neuroendocrine Tumors: To Operate or Not to Published in 2021 Listed under Poster Download [C52] Nguyen - Role of Chromogranin A in the Diagnosis and Follow up of Neuroendocrine Neoplasms: Real World Review Published in 2021 Listed under Poster Download [C53] Pommier - A Prospective Study of Carcinoid Crisis with No Perioperative Octreotide Published in 2021 Listed under Poster Download [C54] Herring - Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors from Black and White Published in 2021 Listed under Poster Download [C55] Pulvirenti - Early Onset Well Differentiated Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathologic Features, and Published in 2021 Listed under Poster Download [C56] DiPeri - Comparison of Patients with Small Bowel Neuroendocrine Tumor Liver Metastaseswith and without Carcinoid Syndrome: A Single Institutional Analysis Published in 2021 Listed under Poster Download [C57] Chauhan - HPG80 (circulating progastrin), a Novel Blood-based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Published in 2021 Listed under Poster Download [C5] Li - Interim analysis results of surufatinib in US patients with neuroendocrine tumors (NETs) Published in 2021 Listed under Poster Download [C6] Guo - Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C7] Halperin - The Safety and Efficacy of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate in Patients (Pts) with Advanced GI Mid-gut Neuroendocrine Tumor (NET): Phase 2 Results Published in 2021 Listed under Poster Download [C8] Reidy-Lagunes - Lanreotide Autogel/Depot (LAN) in Patients with Advanced Bronchopulmonary (BP) Neuroendocrine Tumors (NETs): Results From the Phase 3 SPINET Study Published in 2021 Listed under Poster Download [C9] Siddiqui - Real World Use of Lanreotide in Management of Neuroendocrine Tumours Published in 2021 Listed under Poster Download [O1] Das - A Systematic Survey of Two Decades of Clinical Trials in Neuroendocrine Neoplasms (NENs) Published in 2021 Listed under Poster Download [O2] Yen - The Feasibility and Acceptability of Health and Wellness Coaching for Neuroendocrine Tumor Patients and Their Published in 2021 Listed under Poster Download [O3] Hallet - Patient-reported Cognitive and Psychological Screening in Neuroendocrine Tumors (NETs) - a Prospective Cohort Published in 2021 Listed under Poster Download [O4] Kolarova - Neuroendocrine Tumor Treatments and Follow-up Disease Management - Comparative Perspective (U.S. and Canada Published in 2021 Listed under Poster Download [O5] Hickman - Outcomes of Initial Treatment in Early Stage Neuroendocrine Carcinoma of the Uterine Cervix (NCUC) Published in 2021 Listed under Poster Download [O6] Tsang - Evaluating the Association Between Family History and Overall Survival Among Patients with Gastrointestinal and Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [O7] Wachtel - Succinate Dehydrogenase Pathogenic Variants are Not Associated with Non-canonical Cancers Published in 2021 Listed under Poster Download [O8] Anaka - Understanding Neuroendocrine Tumour Patient Preferences for Medical Management of Midgut NETs Using Discrete Choice Experiments: a DIRECT NETs Study Published in 2021 Listed under Poster Download [P10] Rakshit - Covid-19 in Patients with Neuroendocrine Tumors (NETs): the Mayo Clinic Experience Published in 2021 Listed under Poster Download [P11] Abdelrahman - The Epidemiology of Mixed Acinar Neuroendocrine Carcinoma of the Pancreas in the United States Published in 2021 Listed under Poster Download [P12] Albor - MDT Experience in Argentina in Nets in Times of the Covid19 Pandemic Published in 2021 Listed under Poster Download [P1] Wong - Predictors And Outcomes Of Minimally Invasive Surgery For Small Bowel Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P2] Hallet - Incidence of Psychiatric Illness in Patients With Neuroendocrine Tumors - A Comparative Population-Based Published in 2021 Listed under Poster Download [P3] Bateni - Incidence and Predictors of Second Cancers in Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P4] Bateni - Secondary Primary Cancers and Survival among Neuroendocrine Tumor Patients Published in 2021 Listed under Poster Download [P5] Zarate Rodriguez - Race is an Independent Predictor for Surgery Offer in Patients with Small Bowel Neuroendocrine Tumors But Not Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P6] Zarate Rodriguez - Surgical Interventions in Patients with Pancreatic Neuroendocrine Tumors: a SEER-based Survival Analysis Published in 2021 Listed under Poster Download [P7] Lee - Prevalence and Presentation of Cushing and Carcinoid Syndromes in Patients with Non-metastatic Primary Lung Published in 2021 Listed under Poster Download [P8] Harsha Tella - Association Between Hospital Volume and Overall Survival of Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P9] Mulvey - The Impact of Sociodemographic Factors on Overall Survival for Patients with Adrenocortical Carcinomas in California Published in 2021 Listed under Poster Download [T1] El-Rayes - Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects with Advanced Neuroendocrine Tumors Published in 2021 Listed under Poster Download [T2] Lagast - Dose Selection for Paltusotine, a Once Daily Oral Nonpeptide, Somatostatin Receptor 2 Ligand, for the Treatment of Patients with Carcinoid Syndrome (CS) Published in 2021 Listed under Poster Download [T3] Singh - [177Lu]Lu-DOTA-TATE as First-line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): the NETTER-2 Study Published in 2021 Listed under Poster Download [T4] O'Dorisio - A Phase II Trial to Evaluate the Safety and Dosimetry of [177Lu]Lu-DOTA-TATE in Adolescent Patients with Somatostatin Receptor (SSTR)-positive Gastroenteropancreatic Neuroendocrine Tumors (GEP Published in 2021 Listed under Poster Download [T5] Chauhan - ETCTN 10388: a Phase 1 Trial of Triapine and Lutetium 177 Dotatate in Well-differentiated Somatostatin Receptorpositive Gastroenteropancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download Select the number of documents per page 5 10 15 20 25 30 50 100 12»
